| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 445 |
| 1 | PENTOSAN POLYSULFATE SODIUM | 185 |
| 2 | AFLIBERCEPT | 139 |
| 3 | BEVACIZUMAB | 132 |
| 4 | VERTEPORFIN FOR INJECTION | 87 |
| 5 | OMEPRAZOLE MAGNESIUM | 53 |
| 6 | PREDNISONE | 53 |
| 7 | ADALIMUMAB | 46 |
| 8 | ASPIRIN | 43 |
| 9 | ASPIRIN 325 MG | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERTEPORFIN FOR INJECTION | 87 | 0.0587 |
| 1 | PENTOSAN POLYSULFATE SODIUM | 185 | 0.0267 |
| 2 | RANIBIZUMAB | 445 | 0.0168 |
| 3 | BEVACIZUMAB-ADCD | 3 | 0.0148 |
| 4 | FLUORESCEIN SODIUM | 4 | 0.0130 |
| 5 | BROLUCIZUMAB | 37 | 0.0101 |
| 6 | BETAXOLOL | 6 | 0.0073 |
| 7 | AFLIBERCEPT | 139 | 0.0044 |
| 8 | HYALURONATE SODIUM | 5 | 0.0033 |
| 9 | BEVACIZUMAB-AWWB | 14 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 592 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 107 |
| 2 | Corticosteroid [EPC] | 98 |
| 3 | Photoenhancer [EPC] | 87 |
| 4 | Benzodiazepine [EPC] | 84 |
| 5 | Proton Pump Inhibitor [EPC] | 62 |
| 6 | beta-Adrenergic Blocker [EPC] | 48 |
| 7 | Factor Xa Inhibitor [EPC] | 47 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 45 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 87 | 0.0224 |
| 1 | l-Thyroxine [EPC] | 1 | 0.0204 |
| 2 | Diagnostic Dye [EPC] | 3 | 0.0046 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 592 | 0.0032 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 4 | 0.0018 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 3 | 0.0013 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 2 | 0.0012 |
| 8 | Provitamin D2 Compound [EPC] | 34 | 0.0011 |
| 9 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |